International Society For Cns Drug Development Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 108,239 | 178,156 | −69,917 | 32.2 | — |
| 2012 | 193,613 | 187,809 | 5,804 | 31.0 | — |
| 2013 | 233,357 | 281,064 | −47,707 | 18.7 | 0% |
| 2014 | 161,552 | 214,774 | −53,222 | 21.4 | — |
| 2015 | 234,197 | 149,327 | 84,870 | 37.7 | 0% |
| 2016 | 251,640 | 209,801 | 41,839 | 29.2 | 0% |
| 2017 | 237,890 | 227,052 | 10,838 | 27.1 | 0% |
| 2018 | 223,262 | 197,375 | 25,887 | 33.0 | 0% |
| 2019 | 270,813 | 189,336 | 81,477 | 39.1 | 0% |
| 2020 | 316,917 | 161,254 | 155,663 | 57.5 | 59% |
| 2021 | 237,467 | 218,115 | 19,352 | 43.4 | 55% |
| 2022 | 264,738 | 324,620 | −59,882 | 27.0 | 47% |
| 2023 | 337,601 | 366,257 | −28,656 | 23.0 | 44% |
In its most recent public year (2023), this organization spent $28,656 more than it brought in. Its reserves stood at about 23 months of spending, down from 32.2 in 2011. Staff pay was 44% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works